Risk Of Recurrence After Withdrawal Of Anticoagulation In Patients With Unprovoked Venous Thromboembolism: External Validation Of The Vienna Nomogram And The Dash Prediction Score

被引:6
|
作者
Marin-Romero, Samira [1 ]
Elias-Hernandez, Teresa [1 ]
Isabel Asensio-Cruz, Maria [1 ]
Ortega-Rivera, Rocio [1 ]
Morillo-Guerrero, Raquel [2 ]
Toral, Javier [3 ]
Montero, Emilio [3 ]
Sanchez, Veronica [4 ]
Arellano, Elena [4 ]
Sanchez-Diaz, Jose Maria [1 ]
Real-Dominguez, Macarena [5 ]
Otero-Candelera, Remedios [1 ]
Jara-Palomares, Luis [1 ,6 ]
机构
[1] Hosp Univ Virgen Rocio, Unidad Med Quirurg Enfermedades Resp, Seville, Spain
[2] Hosp Ramon & Cajal, Serv Neumol, Madrid, Spain
[3] Hosp Univ Virgen Rocio, Unidad Urgencias & Emergencias, Seville, Spain
[4] Univ Seville, Hosp Univ Virgen Rocio, CSIC, Inst Biomed Sevilla IBiS, Seville, Spain
[5] Univ Malaga, Dept Med Prevent & Salud Publ, Malaga, Spain
[6] Inst Salud Carlos III, CIBERES, Madrid, Spain
来源
ARCHIVOS DE BRONCONEUMOLOGIA | 2019年 / 55卷 / 12期
关键词
Decision support techniques; Venous thromboembolism; Validation studies (Publication type); Pulmonary embolism; Venous thrombosis; ACUTE PULMONARY-EMBOLISM; ANTITHROMBOTIC THERAPY; DIAGNOSIS; THROMBOSIS; DURATION; RATES; RULE; COHORT; MODEL;
D O I
10.1016/j.arbres.2019.03.025
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Introduction: Scales for predicting venous thromboembolism (VTE) recurrence are useful for deciding the duration of the anticoagulant treatment. Although there are several scales, the most appropriate for our setting has not been identified. For this reason, we aimed to validate the DASH prediction score and the Vienna nomogram at 12 months. Methods: This was a retrospective study of unselected consecutive VTE patients seen between 2006 and 2014. We compared the ability of the DASH score and the Vienna nomogram to predict recurrences of VTE. The validation was performed by stratifying patients as low-risk or high-risk, according to each scale (discrimination) and comparing the observed recurrence with the expected rate (calibration). Results: Of 353 patients evaluated, 195 were analyzed, with an average age of 53.5 +/- 19 years. There were 21 recurrences in 1 year (10.8%, 95% CI: 6.8%-16%). According to the DASH score, 42% were classified as low risk, and the rate of VTE recurrence in this group was 4.9% (95% CI: 1.3%-12%) vs. the high-risk group that was 15% (95% CI: 9%-23%) (p < .05). According to the Vienna nomogram, 30% were classified as low risk, and the rate of VTE recurrence in the low risk group vs. the high risk group was 4.2% (95% CI:0.5%-14%) vs. 16.2% (95% CI: 9.9%-24.4%) (p < .05). Conclusions: Our study validates the DASH score and the Vienna nomogram in our population. The DASH prediction score may be the most advisable, both because of its simplicity and its ability to identify more low-risk patients than the Vienna nomogram (42% vs. 30%). (C) 2019 SEPAR. Published by Elsevier Espana. S.L.U. All rights reserved.
引用
收藏
页码:619 / 626
页数:8
相关论文
共 50 条
  • [41] Association between remote major venous thromboembolism risk factors and the risk of recurrence after a first unprovoked episode
    Farren-Dai, L.
    Carrier, M.
    Kovacs, J.
    Rodger, M.
    Kovacs, M. J.
    Le Gal, G.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2017, 15 (10) : 1977 - 1980
  • [42] Construction and Validation of a Nomogram to Predict the Postoperative Venous Thromboembolism Risk in Patients with HGSOC
    Huang, Zhen
    Li, Ling
    Gong, Zhengxin
    Tang, Liangdan
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2024, 30
  • [43] Predicting Venous Thromboembolism Recurrence Risk in Patients with Cancer: A Validation Study
    Louzada, Martha L.
    Bose, Gauruv
    Cheung, Andrew
    Chin-Yee, Benjamin H.
    Wells, Simon
    Wells, Philip S.
    BLOOD, 2012, 120 (21)
  • [44] External validation of the Khorana score for the prediction of venous thromboembolism in cancer patients: A systematic review and meta-analysis☆
    Huang, Xuan
    Chen, Hongxiu
    Meng, Sha
    Pu, Lihui
    Xu, Xueqiong
    Xu, Ping
    He, Shengyuan
    Hu, Xiuying
    Li, Yong
    Wang, Guan
    INTERNATIONAL JOURNAL OF NURSING STUDIES, 2024, 159
  • [45] Meta-Analysis of Long-Term Risk of Recurrent Venous Thromboembolism After Stopping Anticoagulation in Men and Women with First Unprovoked Venous Thromboembolism
    Khan, Faizan
    Rodger, Marc
    THROMBOSIS RESEARCH, 2018, 170 : 5 - 5
  • [46] Meta-Analysis of Long-Term Risk of Recurrent Venous Thromboembolism after Stopping Anticoagulation in Men and Women with First Unprovoked Venous Thromboembolism
    Khan, Faizan
    Rahman, Alvi
    Carrier, Marc
    Kearon, Clive
    Weitz, Jeffrey I.
    Schulman, Sam
    Couturaud, Francis
    Eichinger, Sabine
    Kyrle, Paul Alexander
    Becattini, Cecilia
    Agnelli, Giancarlo
    Brighton, Timothy
    Lensing, Anthonie Wa.
    Prins, Martin H.
    Sabri, Elham
    Hutton, Brian
    Pinede, Laurent
    Cushman, Mary
    Palareti, Gualtiero
    Wells, George
    Prandoni, Paolo
    Buller, Harry R.
    Rodger, Marc A.
    BLOOD, 2018, 132
  • [47] DERIVATION AND VALIDATION OF A BLEEDING RISK SCORE FOR ELDERLY PATIENTS WITH VENOUS THROMBOEMBOLISM
    Seiler, Eva
    Limacher, Andreas
    Mean, Marie
    Beer, Juerg-Hans
    Osterwalder, Joseph J.
    Frauchiger, Beat
    Righini, Marc
    Aschwanden, Markus
    Matter, Christian M.
    Husmann, Marc
    Banyai, Martin
    Kucher, Nils
    Staub, Daniel
    Lammle, Bernhard
    Angelillo-Scherrer, Anne
    Rodondi, Nicolas
    Aujesky, Drahomir
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2016, 31 : S176 - S177
  • [48] Prediction of venous thromboembolism in newly diagnosed patients treated for lymphoid malignancies: validation of the Khorana Risk Score
    Rupa-Matysek, Joanna
    Gil, Lidia
    Kazmierczak, Maciej
    Baranska, Marta
    Komarnicki, Mieczyslaw
    MEDICAL ONCOLOGY, 2018, 35 (01)
  • [49] Prediction of venous thromboembolism in newly diagnosed patients treated for lymphoid malignancies: validation of the Khorana Risk Score
    Joanna Rupa-Matysek
    Lidia Gil
    Maciej Kaźmierczak
    Marta Barańska
    Mieczysław Komarnicki
    Medical Oncology, 2018, 35
  • [50] Abnormally short activated partial thromboplastin time values are associated with increased risk of recurrence of venous thromboembolism after oral anticoagulation withdrawal
    Legnani, Cristina
    Mattarozzi, Silvia
    Cini, Michela
    Cosmi, Benilde
    Favaretto, Elisabetta
    Palareti, Gualtiero
    BRITISH JOURNAL OF HAEMATOLOGY, 2006, 134 (02) : 227 - 232